Skip to main content

Independent service, not a government website.

Federal grantOpenGrant opportunity

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Department of Health and Human Services, National Institutes of Health

Grant details

Application deadline
Apr 5, 2029
Posted
May 28, 2026
Funding opportunity number
PA-27-101
Grants.gov ID
359758
Funding instrument
Grant
Category of funding
Health
Opportunity category
Discretionary
Award ceiling
Not stated
Award floor
Not stated
Total program funding
Not stated
Expected awards
Not stated
Cost sharing required
Yes
Assistance Listing (ALN/CFDA)
  • 93.233 — National Center on Sleep Disorders Research
  • 93.242 — Mental Health Research Grants
  • 93.273 — Alcohol Research Programs
  • 93.307 — Minority Health and Health Disparities Research
  • 93.313 — NIH Office of Research on Women's Health
  • 93.350 — National Center for Advancing Translational Sciences
  • 93.351 — Research Infrastructure Programs
  • 93.393 — Cancer Cause and Prevention Research
  • 93.394 — Cancer Detection and Diagnosis Research
  • 93.395 — Cancer Treatment Research
  • 93.837 — Cardiovascular Diseases Research
  • 93.838 — Lung Diseases Research
  • 93.839 — Blood Diseases and Resources Research
  • 93.840 — Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
  • 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
  • 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
  • 93.855 — Allergy and Infectious Diseases Research
  • 93.859 — Biomedical Research and Research Training
  • 93.865 — Child Health and Human Development Extramural Research
  • 93.866 — Aging Research
  • 93.867 — Vision Research
Archive date
Jun 4, 2029

Who can apply

Businesses are among the eligible applicants listed on Grants.gov.

  • Small businesses

Additional information on eligibility

Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Description

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

Announcement and documents

No attachments listed in the Grants.gov data. Check the official listing for documents.

Grantor contact

One point of contact is named on the official Grants.gov listing. Sign in to see names, emails and phones here.

As published on the Grants.gov listing. This office in the buyer directory (paid plans and match reports).

Grants: Grants.gov (federal grant opportunities) · last updated Nov 20, 2026, 4:20 PM ET.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Always confirm details, amendments and deadlines on the official listing. Government Bid Finder is an independent service and is not affiliated with or endorsed by the U.S. government.